Aura Biosciences
Developing a new class of therapies to target and destroy cancer cells selectively. Learn more
Launch date
Employees
Market cap
$485m
Enterprise valuation
$317m (Public information from Sep 2024)
Share price
$9.69 AURA
Cambridge Massachusetts (HQ)
Authorizing premium user...